Personal information

Other IDs

Scopus Author ID: 16244973400
Loop profile: 862105

Activities

Collapse all

Works (50 of 79)

Items per page:
Page 1 of 2

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial

Nutrients
2024-06 | Journal article | Author
DOI: 10.3390/nu16132098
Contributors: Debora Macis; Federica Bellerba; VALENTINA ARISTARCO; Harriet Johansson; Aliana Guerrieri Gonzaga; Matteo Lazzeroni; Ivana Sestak; Jack Cuzick; Andrea DeCensi; Bernardo Bonanni et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Prognostic Value of <i>PCSK9</i> Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study

Cancers
2024-04 | Journal article | Author
DOI: 10.3390/cancers16071411
Contributors: Massimiliano Ruscica; Chiara Macchi; Sara Gandini; Debora Macis; Aliana Guerrieri Gonzaga; VALENTINA ARISTARCO; Davide Serrano; Matteo Lazzeroni; Alessandra Stefania Rizzuto; Aurora Gaeta et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Tools to Guide Radiation Oncologists in the Management of DCIS

Healthcare
2024-04 | Journal article | Author
DOI: 10.3390/healthcare12070795
Contributors: Maria Cristina Leonardi; Maria Alessia Zerella; Matteo Lazzeroni; Nicola Fusco; Paolo Veronesi; Viviana Enrica Galimberti; Giovanni Corso; Samantha Dicuonzo; Damaris Patricia Rojas; Anna Morra et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

A mediation analysis of obesity and adiponectin association with postmenopausal breast cancer risk: a nested cohort study in the IBIS-II Prevention Trial

Research Square
2023 | Other
DOI: 10.21203/rs.3.rs-3108856
EID:

2-s2.0-85167536921
Contributors: Macis, D.; Bellerba, F.; Aristarco, V.; Johansson, H.; Guerrieri-Gonzaga, A.; Lazzeroni, M.; Sestak, I.; Cuzick, J.; DeCensi, A.; Bonanni, B. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study

British Journal of Surgery
2023 | Journal article
DOI: 10.1093/bjs/znac391
EID:

2-s2.0-85146139839

Part of ISSN: 13652168 00071323
Contributors: Rossi, E.M.C.; Invento, A.; Pesapane, F.; Pagan, E.; Bagnardi, V.; Fusco, N.; Venetis, K.; Dominelli, V.; Trentin, C.; Cassano, E. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women with Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial

JAMA Oncology
2023 | Journal article
DOI: 10.1001/jamaoncol.2023.0089
EID:

2-s2.0-85159769318

Part of ISSN: 23742445 23742437
Contributors: Serrano, D.; Gandini, S.; Thomas, P.; Crew, K.D.; Kumar, N.B.; Vornik, L.A.; Lee, J.J.; Veronesi, P.; Viale, G.; Guerrieri-Gonzaga, A. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study

Journal of Clinical Oncology
2023 | Journal article
DOI: 10.1200/JCO.22.02900
EID:

2-s2.0-85162988049

Part of ISSN: 15277755 0732183X
Contributors: Lazzeroni, M.; Puntoni, M.; Guerrieri-Gonzaga, A.; Serrano, D.; Boni, L.; Buttiron Webber, T.; Fava, M.; Briata, I.M.; Giordano, L.; Digennaro, M. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer

Healthcare
2023-08 | Journal article | Author
DOI: 10.3390/healthcare11162360
Contributors: Manna, EDF; Davide Serrano; Gaetano Aurilio; Bernardo Bonanni; Matteo Lazzeroni
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation

Annals of Surgery
2022 | Journal article
DOI: 10.1097/SLA.0000000000004969
EID:

2-s2.0-85117443120

Part of ISSN: 15281140 00034932
Contributors: Toesca, A.; Sangalli, C.; Maisonneuve, P.; Massari, G.; Girardi, A.; Baker, J.L.; Lissidini, G.; Invento, A.; Farante, G.; Corso, G. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Advances and controversies in management of breast ductal carcinoma in situ (DCIS)

European Journal of Surgical Oncology
2022 | Journal article
DOI: 10.1016/j.ejso.2021.10.030
EID:

2-s2.0-85118841225

Part of ISSN: 15322157 07487983
Contributors: Farante, G.; Toesca, A.; Magnoni, F.; Lissidini, G.; Vila, J.; Mastropasqua, M.; Viale, G.; Penco, S.; Cassano, E.; Lazzeroni, M. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center

Breast Cancer Research and Treatment
2022 | Journal article
DOI: 10.1007/s10549-022-06689-y
EID:

2-s2.0-85138305521

Part of ISSN: 15737217 01676806
Contributors: Nicosia, L.; Lissidini, G.; Sargenti, M.; Bozzini, A.C.; Farante, G.; Vila, J.; Oriecuia, C.; Pagan, E.; Bagnardi, V.; Lazzeroni, M. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A presurgical study of curcumin combined with anthocyanin supplements in patients with colorectal adenomatous polyps

International Journal of Molecular Sciences
2021 | Journal article
DOI: 10.3390/ijms222011024
EID:

2-s2.0-85116965640

Part of ISSN: 14220067 16616596
Contributors: Briata, I.M.; Paleari, L.; Rutigliani, M.; Petrera, M.; Caviglia, S.; Romagnoli, P.; Libera, M.D.; Oppezzi, M.; Puntoni, M.; Siri, G. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Effect modifiers of low-dose tamoxifen in a randomized trial in breast noninvasive disease

Clinical Cancer Research
2021 | Journal article
DOI: 10.1158/1078-0432.CCR-20-4213
EID:

2-s2.0-85109151116

Part of ISSN: 15573265 10780432
Contributors: DeCensi, A.; Puntoni, M.; Johansson, H.; Guerrieri-Gonzaga, A.; Caviglia, S.; Avino, F.; Cortesi, L.; Ponti, A.; Pacquola, M.G.; Falcini, F. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Low-dose aspirin in high-risk individuals with screen-detected subsolid lung nodules: A randomized phase II trial

JNCI Cancer Spectrum
2021 | Journal article
DOI: 10.1093/JNCICS/PKAA096
EID:

2-s2.0-85100602817

Part of ISSN: 25155091
Contributors: Bonanni, B.; Serrano, D.; Maisonneuve, P.; Veronesi, G.; Johansson, H.; Aristarco, V.; Varricchio, C.; Cazzaniga, M.; Lazzeroni, M.; Rampinelli, C. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Patient- versus physician-reported outcomes in a low-dose tamoxifen trial in noninvasive breast cancer

Breast Journal
2021 | Journal article
DOI: 10.1111/tbj.14296
EID:

2-s2.0-85116565948

Part of ISSN: 15244741 1075122X
Contributors: Buttiron Webber, T.; Marra, D.; Puntoni, M.; Giuliano, S.; Briata, I.M.; Cevasco, I.; Clavarezza, M.; D’Amico, M.; Defferrari, C.; Gozza, A. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Response to Braillon

JNCI Cancer Spectrum
2021 | Journal article
DOI: 10.1093/jncics/pkab005
EID:

2-s2.0-85141833347

Part of ISSN: 25155091
Contributors: Bonanni, B.; Serrano, D.; Maisonneuve, P.; Lazzeroni, M.; Brown, P.H.; Guerrieri-Gonzaga, A.; Szabo, E.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A Novel Automated Immunoassay Platform to Evaluate the Association of Adiponectin and Leptin Levels with Breast Cancer Risk

Cancers
2021-06 | Journal article | Author
DOI: 10.3390/cancers13133303
Contributors: Debora Macis; VALENTINA ARISTARCO; Harriet Johansson; Aliana Guerrieri-Gonzaga; Sara Raimondi; Matteo Lazzeroni; Ivana Sestak; Jack Cuzick; Andrea DeCensi; Bernardo Bonanni et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate?

Diagnostics
2021-06 | Journal article | Author
DOI: 10.3390/diagnostics11061120
Contributors: Luca Nicosia; Antuono Latronico; Francesca Addante; Rossella De Santis; Anna Carla Bozzini; Marta Montesano; Samuele Frassoni; Vincenzo Bagnardi; Giovanni Mazzarol; Oriana Pala et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics

Nutrients
2021-05 | Journal article | Author
DOI: 10.3390/nu13051736
Contributors: Matteo Lazzeroni; Federica Bellerba; Mariarosaria Calvello; Finlay Macrae; Aung Ko Win; Mark Jenkins; Davide Serrano; Monica Marabelli; Sara Cagnacci; Gianluca Tolva et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Complete Removal of the Lesion as A Guidance in the Management of Patients with Breast Ductal Carcinoma in Situ

Cancers
2021-02 | Journal article | Author
DOI: 10.3390/cancers13040868
Contributors: Luca Nicosia; Giuseppe di Giulio; Anna Carla Bozzini; Marianna Fanizza; Francesco Ballati; Anna Rotili; Matteo Lazzeroni; Antuono Latronico; Francesca Abbate; Giuseppe Renne et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A Soft Option for Primary Prevention: Drugs and Agents

Breast MRI for High-risk Screening
2020 | Book chapter
Part of DOI: 10.1007/978-3-030-41207-4_17
EID:

2-s2.0-85150124965
Contributors: Bonanni, B.; Cazzaniga, M.; Lazzeroni, M.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

De-escalating treatment of low-risk breast ductal carcinoma in situ

Journal of Clinical Oncology
2020 | Journal article
DOI: 10.1200/JCO.20.00124
EID:

2-s2.0-85083546674

Part of ISSN: 15277755 0732183X
Contributors: Lazzeroni, M.; DeCensi, A.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?

Digestive and Liver Disease
2020 | Journal article
DOI: 10.1016/j.dld.2020.06.002
EID:

2-s2.0-85087219815

Part of ISSN: 18783562 15908658
Contributors: Marabelli, M.; Gandini, S.; Rafaniello, P.R.; Calvello, M.; Tolva, G.; Feroce, I.; Lazzeroni, M.; Marino, E.; Dal Molin, M.; Trovato, C. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast

Modern Pathology
2020 | Journal article
DOI: 10.1038/s41379-020-0452-0
EID:

2-s2.0-85077844478
Contributors: Lazzeroni, M.; DeCensi, A.; Guerrieri-Gonzaga, A.; Pagan, E.; Bagnardi, V.; Macis, D.; Serrano, D.; Vingiani, A.; Bonizzi, G.; Barberis, M. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

Pharmacogenomics Journal
2020 | Journal article
DOI: 10.1038/s41397-019-0087-z
EID:

2-s2.0-85064035719
Contributors: Johansson, H.; Aristarco, V.; Gandini, S.; Gjerde, J.; Macis, D.; Guerrieri-Gonzaga, A.; Serrano, D.; Lazzeroni, M.; Rajasekaran, A.; Williard, C.V. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue

Molecules
2020-06 | Journal article | Author
DOI: 10.3390/molecules25122918
Contributors: Matteo Lazzeroni; Giovanna Petrangolini; José Antonio Legarreta Iriberri; Jaume Pascual Avellana; Digna Tost Robusté; Sara Cagnacci; Debora Macis; Valentina Aristarco; Bernardo Bonanni; Paolo Morazzoni et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series

Radiotherapy and Oncology
2019 | Journal article
DOI: 10.1016/j.radonc.2018.12.030
EID:

2-s2.0-85060011973
Contributors: Leonardi, M.C.; Corrao, G.; Frassoni, S.; Vingiani, A.; Dicuonzo, S.; Lazzeroni, M.; Fodor, C.; Morra, A.; Gerardi, M.A.; Rojas, D.P. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast

Breast
2019 | Journal article
DOI: 10.1016/S0960-9776(19)31121-X
EID:

2-s2.0-85076311465
Contributors: Lazzeroni, M.; Puntoni, M.; Provinciali, N.; Webber, T.B.; Briata, I.M.; D'Amico, M.; Giuliano, S.; Siri, G.; Cagnacci, S.; DeCensi, A.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia

Journal of Clinical Oncology
2019 | Journal article
DOI: 10.1200/JCO.18.01779
EID:

2-s2.0-85065849570
Contributors: DeCensi, A.; Puntoni, M.; Guerrieri-Gonzaga, A.; Caviglia, S.; Avino, F.; Cortesi, L.; Taverniti, C.; Pacquola, M.G.; Falcini, F.; Gulisano, M. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis

Critical Reviews in Oncology/Hematology
2019 | Journal article
DOI: 10.1016/j.critrevonc.2018.12.009
EID:

2-s2.0-85059781599
Contributors: Gandini, S.; Lazzeroni, M.; Peccatori, F.A.; Bendinelli, B.; Saieva, C.; Palli, D.; Masala, G.; Caini, S.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Metformin

Encyclopedia of Cancer
2018 | Book
Part of DOI: 10.1016/B978-0-12-801238-3.65133-4
EID:

2-s2.0-85063965187
Contributors: Lazzeroni, M.; Gandini, S.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A presurgical study of lecithin formulation of green tea extract in women with early breast cancer

Cancer Prevention Research
2017 | Journal article
DOI: 10.1158/1940-6207.CAPR-16-0298
EID:

2-s2.0-85020310477
Contributors: Lazzeroni, M.; Guerrieri-Gonzaga, A.; Gandini, S.; Johansson, H.; Serrano, D.; Cazzaniga, M.; Aristarco, V.; MacIs, D.; Mora, S.; Caldarella, P. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box

Cancer Treatment Reviews
2017 | Journal article
DOI: 10.1016/j.ctrv.2017.01.010
EID:

2-s2.0-85014293044
Contributors: Lazzeroni, M.; Dunn, B.K.; Pruneri, G.; Jereczek-Fossa, B.A.; Orecchia, R.; Bonanni, B.; DeCensi, A.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Circulating and tissue biomarkers in early-stage non-small cell lung cancer

ecancermedicalscience
2017 | Journal article
DOI: 10.3332/ecancer.2017.717
EID:

2-s2.0-85012890469
Contributors: Fumagalli, C.; Bianchi, F.; Raviele, P.R.; Vacirca, D.; Bertalot, G.; Rampinelli, C.; Lazzeroni, M.; Bonanni, B.; Veronesi, G.; Fusco, N. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

Annals of Oncology
2017 | Journal article
DOI: 10.1093/annonc/mdw623
EID:

2-s2.0-85014280869
Contributors: Pruneri, G.; Lazzeroni, M.; Bagnardi, V.; Tiburzio, G.B.; Rotmensz, N.; DeCensi, A.; Guerrieri-Gonzaga, A.; Vingiani, A.; Curigliano, G.; Zurrida, S. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancer

Cancer Prevention Research
2016 | Journal article
DOI: 10.1158/1940-6207.CAPR-15-0123
EID:

2-s2.0-84955319515
Contributors: Lazzeroni, M.; Guerrieri-Gonzaga, A.; Gandini, S.; Johansson, H.; Serrano, D.; Cazzaniga, M.; Aristarco, V.; Puccio, A.; Mora, S.; Caldarella, P. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A randomized, placebo-controlled, phase II, presurgical biomarker trial of Celecoxib versus exemestane in postmenopausal breast cancer patients

Cancer Prevention Research
2016 | Journal article
DOI: 10.1158/1940-6207.CAPR-15-0311
EID:

2-s2.0-84969922808
Contributors: Aristarco, V.; Serrano, D.; Gandini, S.; Johansson, H.; Macis, D.; Guerrieri-Gonzaga, A.; Lazzeroni, M.; Feroce, I.; Pruneri, G.; Pagani, G. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Alternate dosing schedules for cancer chemopreventive agents

Seminars in Oncology
2016 | Journal article
DOI: 10.1053/j.seminoncol.2015.09.014
EID:

2-s2.0-84960440949
Contributors: Lazzeroni, M.; DeCensi, A.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS

International Journal of Cancer
2016 | Journal article
DOI: 10.1002/ijc.30254
EID:

2-s2.0-84983028353
Contributors: Guerrieri-Gonzaga, A.; Sestak, I.; Lazzeroni, M.; Serrano, D.; Rotmensz, N.; Cazzaniga, M.; Varricchio, C.; Pruneri, G.; Leonardi, M.C.; Orecchia, R. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches

Molecular Oncology
2015 | Journal article
DOI: 10.1016/j.molonc.2014.12.006
EID:

2-s2.0-84928582571
Contributors: Serrano, D.; Lazzeroni, M.; Bonanni, B.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Effect of metformin on breast ductal carcinoma in situ proliferation in a randomized presurgical trial

Cancer Prevention Research
2015 | Journal article
DOI: 10.1158/1940-6207.CAPR-15-0048
EID:

2-s2.0-84943277146
Contributors: Decensi, A.; Puntoni, M.; Guerrieri-Gonzaga, A.; Cazzaniga, M.; Serrano, D.; Lazzeroni, M.; Vingiani, A.; Gentilini, O.; Petrera, M.; Viale, G. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Long-term effects of inhaled budesonide on screening-detected lung nodules

Annals of Oncology
2015 | Journal article
DOI: 10.1093/annonc/mdv064
EID:

2-s2.0-84929086937
Contributors: Veronesi, G.; Lazzeroni, M.; Szabo, E.; Brown, P.H.; Decensi, A.; Guerrieri-Gonzaga, A.; Bellomi, M.; Radice, D.; Grimaldi, M.C.; Spaggiari, L. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Metformin: Risk-benefit profile with a focus on cancer

Expert Opinion on Drug Safety
2015 | Journal article
DOI: 10.1517/14740338.2015.1084289
EID:

2-s2.0-84942295530
Contributors: Provinciali, N.; Lazzeroni, M.; Cazzaniga, M.; Gorlero, F.; Dunn, B.K.; Decensi, A.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ

Annals of Oncology
2015 | Journal article
DOI: 10.1093/annonc/mdv013
EID:

2-s2.0-84926480393
Contributors: Curigliano, G.; Disalvatore, D.; Esposito, A.; Pruneri, G.; Lazzeroni, M.; Guerrieri-Gonzaga, A.; Luini, A.; Orecchia, R.; Goldhirsch, A.; Rotmensz, N. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Annals of Oncology
2014 | Journal article
DOI: 10.1093/annonc/mdt528
EID:

2-s2.0-84896808684
Contributors: Gandini, S.; Guerrieri-Gonzaga, A.; Pruneri, G.; Serrano, D.; Cazzaniga, M.; Lazzeroni, M.; Veronesi, P.; Johansson, H.; Bonanni, B.; Viale, G. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence

Breast
2014 | Journal article
DOI: 10.1016/j.breast.2014.08.016
EID:

2-s2.0-84921974512
Contributors: Toesca, A.; Botteri, E.; Lazzeroni, M.; Vila, J.; Manika, A.; Ballardini, B.; Bettarini, F.; Guerrieri-Gonzaga, A.; Bonanni, B.; Rotmensz, N. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial

Breast Cancer Research and Treatment
2014 | Journal article
DOI: 10.1007/s10549-014-3141-1
EID:

2-s2.0-84922005443
Contributors: DeCensi, A.; Puntoni, M.; Gandini, S.; Guerrieri-Gonzaga, A.; Johansson, H.A.; Cazzaniga, M.; Pruneri, G.; Serrano, D.; Schwab, M.; Hofmann, U. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mdt244
EID:

2-s2.0-84887071898
Contributors: DeCensi, A.; Bonanni, B.; Maisonneuve, P.; Serrano, D.; Omodei, U.; Varricchio, C.; Cazzaniga, M.; Lazzeroni, M.; Rotmensz, N.; Santillo, B. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Breast Cancer Research
2013 | Journal article
DOI: 10.1186/bcr3439
EID:

2-s2.0-84879108889
Contributors: Serrano, D.; Lazzeroni, M.; Gandini, S.; Macis, D.; Johansson, H.; Gjerde, J.; Lien, E.; Feroce, I.; Pruneri, G.; Sandri, M.T. et al.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier

Acceptability of chemoprevention trials in high-risk subjects

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mdt328
EID:

2-s2.0-84886283213
Contributors: Bonanni, B.; Lazzeroni, M.
Source: Self-asserted source
Matteo Lazzeroni via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (4 reviews for 4 publications/grants)

Review activity for Critical reviews in oncology/hematology. (1)
Review activity for Drugs (1)
Review activity for European journal of cancer. (1)
Review activity for The Breast. (1)
How many people are using ORCID?